PT102343A - Processo para a preparacao de furoato mometasona - Google Patents

Processo para a preparacao de furoato mometasona

Info

Publication number
PT102343A
PT102343A PT102343A PT10234399A PT102343A PT 102343 A PT102343 A PT 102343A PT 102343 A PT102343 A PT 102343A PT 10234399 A PT10234399 A PT 10234399A PT 102343 A PT102343 A PT 102343A
Authority
PT
Portugal
Prior art keywords
furoate
momethasone
preparation
mometasone
free
Prior art date
Application number
PT102343A
Other languages
English (en)
Other versions
PT102343B (pt
Inventor
William Heggie
Original Assignee
Hovione Sociedade Quimica S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hovione Sociedade Quimica S A filed Critical Hovione Sociedade Quimica S A
Priority to PT102343A priority Critical patent/PT102343B/pt
Priority to NZ500555A priority patent/NZ500555A/xx
Priority to HU9903747A priority patent/HU227494B1/hu
Priority to AU56024/99A priority patent/AU765592B2/en
Priority to DE69904585T priority patent/DE69904585T2/de
Priority to DK99308380T priority patent/DK1074558T3/da
Priority to AT99308380T priority patent/ATE229970T1/de
Priority to SI9930173T priority patent/SI1074558T1/xx
Priority to EP99308380A priority patent/EP1074558B1/en
Priority to ES99308380T priority patent/ES2189354T3/es
Priority to NO19995225A priority patent/NO321154B1/no
Priority to ZA9906758A priority patent/ZA996758B/xx
Priority to KR1019990048285A priority patent/KR100640066B1/ko
Priority to RU99123183/04A priority patent/RU2208616C2/ru
Priority to UA99116069A priority patent/UA60333C2/uk
Priority to PL336452A priority patent/PL191103B1/pl
Priority to HR990341A priority patent/HRP990341B1/xx
Priority to JP31523699A priority patent/JP3746174B2/ja
Priority to CNB991243803A priority patent/CN1149222C/zh
Priority to IL13375299A priority patent/IL133752A/en
Priority to US09/476,004 priority patent/US6177560B1/en
Priority to CA002295455A priority patent/CA2295455C/en
Publication of PT102343A publication Critical patent/PT102343A/pt
Publication of PT102343B publication Critical patent/PT102343B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT102343A 1999-08-02 1999-08-02 Processo para a preparacao de furoato mometasona PT102343B (pt)

Priority Applications (22)

Application Number Priority Date Filing Date Title
PT102343A PT102343B (pt) 1999-08-02 1999-08-02 Processo para a preparacao de furoato mometasona
NZ500555A NZ500555A (en) 1999-08-02 1999-08-02 Process for the preparation of mometasone furoate
HU9903747A HU227494B1 (en) 1999-08-02 1999-10-21 New process for the preparation of mometasone furoate
AU56024/99A AU765592B2 (en) 1999-08-02 1999-10-22 Process for the preparation of mometasone furoate
DE69904585T DE69904585T2 (de) 1999-08-02 1999-10-25 Verfahren zur Herstellung von Mometason Furoat
DK99308380T DK1074558T3 (da) 1999-08-02 1999-10-25 Proces til fremstilling af mometasonefuroat
AT99308380T ATE229970T1 (de) 1999-08-02 1999-10-25 Verfahren zur herstellung von mometason furoat
SI9930173T SI1074558T1 (en) 1999-08-02 1999-10-25 Process for the preparation of mometasone furoate
EP99308380A EP1074558B1 (en) 1999-08-02 1999-10-25 Process for the preparation of mometasone furoate
ES99308380T ES2189354T3 (es) 1999-08-02 1999-10-25 Procedimiento para la preparacion de furoato mometasona.
NO19995225A NO321154B1 (no) 1999-08-02 1999-10-26 Fremgangsmate ved fremstilling av mometason furoat
ZA9906758A ZA996758B (en) 1999-08-02 1999-10-27 Process for the preparation of mometasone furoate.
KR1019990048285A KR100640066B1 (ko) 1999-08-02 1999-11-03 모메타손 푸로에이트의 제조방법
RU99123183/04A RU2208616C2 (ru) 1999-08-02 1999-11-03 Способ получения фуроата мометазона
UA99116069A UA60333C2 (uk) 1999-08-02 1999-11-04 Спосіб одержання фуроату мометазону
PL336452A PL191103B1 (pl) 1999-08-02 1999-11-05 Sposób wytwarzania furanianu mometazonu
HR990341A HRP990341B1 (en) 1999-08-02 1999-11-05 Process for the preparation of mometasone furoate
JP31523699A JP3746174B2 (ja) 1999-08-02 1999-11-05 モメタゾンフロエートの製造方法
CNB991243803A CN1149222C (zh) 1999-08-02 1999-11-26 糠酸莫米松的制备方法
IL13375299A IL133752A (en) 1999-08-02 1999-12-27 Process for Momatazone Foroat
US09/476,004 US6177560B1 (en) 1999-08-02 1999-12-29 Process for the preparation of mometasone furoate
CA002295455A CA2295455C (en) 1999-08-02 2000-01-14 Process for the preparation of mometasone furoate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT102343A PT102343B (pt) 1999-08-02 1999-08-02 Processo para a preparacao de furoato mometasona

Publications (2)

Publication Number Publication Date
PT102343A true PT102343A (pt) 2001-02-28
PT102343B PT102343B (pt) 2003-11-28

Family

ID=20085881

Family Applications (1)

Application Number Title Priority Date Filing Date
PT102343A PT102343B (pt) 1999-08-02 1999-08-02 Processo para a preparacao de furoato mometasona

Country Status (22)

Country Link
US (1) US6177560B1 (pt)
EP (1) EP1074558B1 (pt)
JP (1) JP3746174B2 (pt)
KR (1) KR100640066B1 (pt)
CN (1) CN1149222C (pt)
AT (1) ATE229970T1 (pt)
AU (1) AU765592B2 (pt)
CA (1) CA2295455C (pt)
DE (1) DE69904585T2 (pt)
DK (1) DK1074558T3 (pt)
ES (1) ES2189354T3 (pt)
HR (1) HRP990341B1 (pt)
HU (1) HU227494B1 (pt)
IL (1) IL133752A (pt)
NO (1) NO321154B1 (pt)
NZ (1) NZ500555A (pt)
PL (1) PL191103B1 (pt)
PT (1) PT102343B (pt)
RU (1) RU2208616C2 (pt)
SI (1) SI1074558T1 (pt)
UA (1) UA60333C2 (pt)
ZA (1) ZA996758B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
EP1790754A1 (de) * 2005-11-24 2007-05-30 Siemens Aktiengesellschaft Schichtsystem mit Gadolinium-Mischkristall-Pyrochlorphase
US8021742B2 (en) * 2006-12-15 2011-09-20 Siemens Energy, Inc. Impact resistant thermal barrier coating system
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
RU2580315C3 (ru) 2009-05-29 2021-06-18 Перл Терапьютикс, Инк. Композиции для респираторной доставки активных веществ и связанные с ними способы и системы
PT105139B (pt) * 2010-06-01 2013-01-29 Hovione Farmaciencia S A Método para a monofluorometilação de substratos orgânicos para preparação de compostos orgânicos biologicamente activos
SG11201507286QA (en) 2013-03-15 2015-10-29 Pearl Therapeutics Inc Methods and systems for conditioning of particulate crystalline materials
EP2999460A1 (en) 2013-05-22 2016-03-30 Pearl Therapeutics, Inc. Compositions, methods&systems for respiratory delivery of three or more active agents
CN105481933B (zh) * 2015-12-25 2017-09-19 山东京卫制药有限公司 一种合成糠酸莫米松的方法
CN105566437B (zh) * 2015-12-30 2018-07-20 山东京卫制药有限公司 一种8dm衍生物及利用其合成糠酸莫米松的方法
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法
MX2024000468A (es) 2021-07-09 2024-04-05 Astrazeneca Pharmaceuticals Lp Composiciones, metodos y sistemas para la administracion de farmacos en aerosol.
CN118414148A (zh) 2021-12-20 2024-07-30 阿斯利康(瑞典)有限公司 用于气溶胶药物递送的组合物、方法和系统

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1359A (en) * 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
CZ293944B6 (cs) * 1996-06-28 2004-08-18 Scheringácorporation Způsob přípravy �@esterů @alfaŹ@�@dihalogenpregnan@��betaŹ�@alfa@diol@onů
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones

Also Published As

Publication number Publication date
NZ500555A (en) 2000-11-24
HUP9903747A3 (en) 2001-07-30
DE69904585D1 (de) 2003-01-30
HU227494B1 (en) 2011-07-28
KR100640066B1 (ko) 2006-10-31
ES2189354T3 (es) 2003-07-01
SI1074558T1 (en) 2003-04-30
US6177560B1 (en) 2001-01-23
KR20010020094A (ko) 2001-03-15
NO321154B1 (no) 2006-03-27
AU765592B2 (en) 2003-09-25
DK1074558T3 (da) 2003-04-07
HRP990341A2 (en) 2001-04-30
NO995225D0 (no) 1999-10-26
PT102343B (pt) 2003-11-28
HRP990341B1 (en) 2003-10-31
ZA996758B (en) 2000-08-30
CA2295455C (en) 2008-03-25
CN1282744A (zh) 2001-02-07
JP3746174B2 (ja) 2006-02-15
NO995225L (no) 2001-02-05
CN1149222C (zh) 2004-05-12
UA60333C2 (uk) 2003-10-15
RU2208616C2 (ru) 2003-07-20
HUP9903747A2 (hu) 2001-05-28
HU9903747D0 (en) 1999-12-28
IL133752A0 (en) 2001-04-30
EP1074558A1 (en) 2001-02-07
EP1074558B1 (en) 2002-12-18
JP2001048897A (ja) 2001-02-20
DE69904585T2 (de) 2003-05-15
IL133752A (en) 2004-02-19
AU5602499A (en) 2001-02-08
CA2295455A1 (en) 2001-02-02
PL336452A1 (en) 2001-02-12
PL191103B1 (pl) 2006-03-31
ATE229970T1 (de) 2003-01-15

Similar Documents

Publication Publication Date Title
PT102343A (pt) Processo para a preparacao de furoato mometasona
ATE181551T1 (de) Taxol-derivate
DK1870417T3 (da) Peptidacceptor-ligeringsmetoder
EP1401433A4 (en) CONSTANTLY CONFORMING ANALOGUES AS AGENTS AGAINST DIABETES AND AGAINST OBESITY, AND ASSOCIATED METHOD
BR9807502B1 (pt) compostos orgÂnicos, processo para sua preparaÇço, bem como composiÇço e aplicaÇço dos mesmos.
BR9912109B1 (pt) compostos derivados de quinolina, composições farmacêuticas, processo para a manufatura de um composto, e, uso de um composto.
ATE429920T1 (de) Pharmazeutische zusammensetzung und verfahren zur behandlung von hypogonadismus
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
DE69735634D1 (de) Substituierte cyclopentanderivate die als neuramidase-inhibitoren nuetzlich sind
ES2181744T3 (es) Hidratos de paclitaxel cristalinos.
ES2128519T3 (es) Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
BR0311940A (pt) Difenilazetidinonas substituìdas no anel, processo para produção das mesmas, medicamentos que contêm esses compostos e uso dos mesmos
BR9205854A (pt) Composiçoes de mistura curavel por UV e processos.
ES2154560B1 (es) Composicion a base de derivados de cromanos y su uso para reducir quimicamente las reacciones oxidativas o inducidas por radicales libres.
FR2831548B1 (fr) Composition silicone adhesive reticulable comprenant comme agent thixotropant un compose a fonction amine cyclique portee par une chaine siloxanique
DE69814943D1 (de) Silizium enthaltende Verbindung und organische elektrolumineszente Vorrichtung, in welcher diese verwendet wird.
DE4493718T1 (de) Abbaubare Succinsäurederivatchelanten, Verwendungen und Zusammensetzungen davon
BR9402686A (pt) Processo para a preparação de poliéteres, poliéteres, composição, processo para estabilizar polímeros orgânicos e aplicação.
PT1204659E (pt) Benzofuranos serotoninergicos
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
ITFI990169A0 (it) Analoghi di ceramidi, processo per la loro preparazione e loro uso come antitumorali.
AU2001260616A1 (en) Compounds generating amine by irradiation with light, photo-setting compositions and photoreactive adhesive compositions
BR9807312B1 (pt) Derivados de (4-piperidinil)-1h-2-benzopirano úteis como agentes antipsicóticos, composição farmacêutica e processo para a preparação dos referidos derivados
ATE374177T1 (de) Cyclohexyl(alkyl)-propanolamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE469902T1 (de) Amorphe substanz eines tricyclischen triazolobenzazepinderivats

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19991008